Subscribe

Press Release

Jun- 2026 -

18 June

Cision PR Newswire

Six Taipei Biotechs Head to BIO 2026 in San Diego, With Precision Medicine, Drug Delivery, and Bioprocess Innovation in Focus
Read More »
18 June

Cision PR Newswire

VinFast VF 8: The Electric SUV That Puts Family First
Read More »
18 June

Cision PR Newswire

Envoy Global Releases 11th Annual Immigration Trends Report as Employers Adapt to Rapid Changes in U.S. Immigration Policy
Read More »
18 June

Cision PR Newswire

Newo.ai to showcase AI receptionists at InstallerSHOW
Read More »
18 June

Cision PR Newswire

THRYVE Automation announces advanced end-to-end automation solutions to help manufacturers meet modern AI and workforce challenges
Read More »
18 June

Cision PR Newswire

Airport Navigational Aids Market worth $4.41 billion by 2031 – Exclusive Report by MarketsandMarkets™
Read More »
18 June

Cision PR Newswire

IASO Bio Announces NDA Approval of Equecabtagene Autoleucel by the Singapore Health Sciences Authority (HSA) for the Treatment of Relapsed or Refractory Multiple Myeloma, Marking a Key Milestone in International Commercialization
Read More »
18 June

Cision PR Newswire

Zoomlion Highlights AI, Green Technology and Global R&D Priorities at Seventh Technology Innovation Conference
Read More »
18 June

Cision PR Newswire

Uxin Announces Management Share Purchase Plan
Read More »
18 June

Cision PR Newswire

TORL BioTherapeutics Presents Preliminary Safety and Efficacy Data of Ixotatug Vedotin (TORL-1-23) in Combination with Bevacizumab in Recurrent Ovarian Cancer at ESMO Gynaecological Cancers Congress 2026
Read More »

Previous page Next page